2021年10期
刊物介紹
本刊主要出版來自成年神經(jīng)元的轉(zhuǎn)化與再生；損傷神經(jīng)元的軸突和樹突的修復(fù)與再生；神經(jīng)再生過程中神經(jīng)元、微環(huán)境、新生血管的變化；神經(jīng)損傷后的干預(yù)、修復(fù)、保護(hù)與再生的組織形態(tài)學(xué)變化乃至細(xì)胞生物學(xué)或細(xì)胞分子生物學(xué)的改變；神經(jīng)再生研究中的新理論、新技術(shù)、新方法。NRR雜志希望成為國際神經(jīng)再生領(lǐng)域讀者、作者和專業(yè)學(xué)者最喜歡、最認(rèn)可的優(yōu)秀的專業(yè)性學(xué)術(shù)期刊。 br 期刊官方網(wǎng)站： (英文)； （中文） br 期刊投稿網(wǎng)站：
中國神經(jīng)再生研究（英文版）
- Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders
- The role of gap junctions in cell death and neuromodulation in the retina
- Don’t know what you got till it’s gone: microglial depletion and neurodegeneration
- Notice of Retraction
- Low-dose lipopolysaccharide as an immune regulator for homeostasis maintenance in the central nervous system through transformation to neuroprotective microglia
- Protein post-translational modifications after spinal cord injury
- Proteolysis targeting chimera technology: a novel strategy for treating diseases of the central nervous system
- Axonal mRNA localization and local translation in neurodegenerative diseases
- Alzheimer’s disease: a tale of two diseases?
- Sleep disorders in Alzheimer’s disease: the predictive roles and potential mechanisms
- The plasminogen activating system in the pathogenesis of Alzheimer’s disease
- Corrigendum
- Emerging concepts underlying selective neuromuscular dysfunction in infantile-onset spinal muscular atrophy
- Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
- A paradigm shift: emerging roles of microglia, a non-neuronal cell, in learning and memory
- Slc7a5 regulation of neural development
- MicroRNA-based therapeutics for optic neuropathy: opportunities and challenges
- In vivo direct reprogramming as a therapeutic strategy for brain and retina repair
- Intravitreal fluorogold tracing as a method to label retinal neurons and the retinal pigment epithelium
- OTX2 signaling in retinal dysfunction,degeneration and regeneration
- Modulation of brainstem reflexes induced by non-invasive brain stimulation: is there a future?
- High mobility group box-1 protein as a therapeutic target in perinatal hypoxic-ischemic brain injury
- Regulating autophagy: a novel role for SETX (Senataxin)
- Biomarker-guided drug therapy:personalized medicine for treating Alzheimer’s disease
- How would preclinical Alzheimer’s disease (AD pathology) occur? An insight from a genomic instability mouse model
- Short-chain fatty acids in the context of Parkinson’s disease
- Non-coding RNAs and stem cells: the dream team for neural regeneration in Parkinson’s disease?
- The dual role of necrostatin-1 in Parkinson’s disease models
- Potential role of biofeedback therapy for Parkinson’s disease
- Pharmacological interventions targeting nuclear factor-kappa B signaling in multiple sclerosis
- Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns
- Nuclear sphingomyelin in neurodegenerative diseases
- Arbutin effectively ameliorates the symptoms of Parkinson’s disease: the role of adenosine receptors and cyclic adenosine monophosphate
- β2 and α2 adrenergic receptors mediate the proneurogenic in vitro effects of norquetiapine
- Role of circular RNA expression in the pathological progression after spinal cord injury
- Methylene blue enhances polyethylene glycol-fusion repair of completely severed rat sciatic nerves
- Exosomes derived from human induced pluripotent stem cell-derived neural progenitor cells protect neuronal function under ischemic conditions
- The role of pineal microRNA-325 in regulating circadian rhythms after neonatal hypoxic-ischemic brain damage
- Markers for neural degeneration and regeneration:novel highly sensitive methods for the measurement of thrombin and activated protein C in human cerebrospinal fluid
- Fluoxetine, a selective serotonin reuptake inhibitor used clinically, improves bladder function in a mouse model of moderate spinal cord injury
- MicroRNA and mRNA profiling of cerebral cortex in a transgenic mouse model of Alzheimer’s disease by RNA sequencing
- Luteolin delays photoreceptor degeneration in a mouse model of retinitis pigmentosa
- Combined treatment with valproic acid and estrogen has neuroprotective effects in ovariectomized mice with Alzheimer’s disease